What to expect: Cross-class switch from pure GLP-1 (dulaglutide) to dual GIP/GLP-1 (tirzepatide). Same T2D indication. Restart titration from Mounjaro 2.5 mg. Allow GI adjustment.
Washout window: ~7 days for Trulicity to clear
Why patients switch from Trulicity to Mounjaro
- Greater A1C reduction — SURPASS-2 head-to-head: tirzepatide reduced A1C ~2.3% vs semaglutide ~1.9%
- Greater weight loss — Mounjaro produces ~15-20 lb vs Trulicity ~3-7 lb at max doses
- Plateau on max Trulicity dose (4.5 mg) without reaching A1C goal
- Insurance shifted preferred T2D formulary to Mounjaro
- Both are Lilly products — common provider preference path
Side effects during the Trulicity → Mounjaro transition
- Nausea (tirzepatide > dulaglutide for GI burden)
- Constipation
- Decreased appetite (more pronounced on Mounjaro)
- A1C may dip more rapidly during transition
Discuss with your prescriber before switching
This guide is editorial — not medical advice. Switching GLP-1 medications must be supervised. Bring this checklist to your appointment:
- Required — A1C target review
- If on insulin/sulfonylurea (hypoglycemia risk)
- If history of medullary thyroid cancer or MEN-2 (contraindication for both)
Dose conversion: Trulicity → Mounjaro
Use this table as a starting reference only. Final dose depends on your tolerance, weight-loss trajectory, and prescriber guidance. Never self-titrate based on a chart.
| Trulicity dose | Mounjaro dose | Note |
|---|---|---|
| Any | Restart titration from lowest dose | Different mechanism (dulaglutide → tirzepatide). No direct conversion. |
Transition timeline
Plan on 2-week prep + 12-week evaluation window. Most weight-loss outcomes can be re-assessed at the 12-week mark on the new medication.
Week −2: Decision + prescriber alignment
Confirm with your prescriber: dose-equivalent target, expected side-effect profile differences (dulaglutide → tirzepatide), insurance implications.
Week −1: Last Trulicity dose
Continue your current Trulicity schedule. Trulicity has a long half-life — semaglutide ~1 week, tirzepatide ~5 days — so effects persist for days after stopping.
Week 0: First Mounjaro dose
Restart titration from lowest Mounjaro dose. Overlap effect possible in the first 7-10 days as Trulicity clears.
Weeks 1-4: Stabilization
Side-effect profile shifts. GI symptoms (nausea, constipation) may be more pronounced. Track weight + appetite.
Weeks 4-12: Re-evaluation
Compare outcomes to your Trulicity baseline. If weight-loss trajectory hasn't improved by week 12, discuss whether the switch was right.
Beyond 12 weeks
If outcomes good, continue. If switch underperformed Trulicity, discuss reverting or trying a third option (often semaglutide-based).
FAQ — Trulicity → Mounjaro
Can I take Trulicity and Mounjaro together?
No. Combining GLP-1 medications isn't done outside clinical trials. Stop Trulicity before starting Mounjaro; the long half-lives mean overlap occurs naturally.
Will I lose ground when switching from Trulicity to Mounjaro?
Possibly temporarily. Most patients maintain weight during a clean switch when restart dose is appropriate. The bigger risk is regression if the switch fails to match Trulicity efficacy. Plan and 12-week evaluation window.
Does insurance cover Mounjaro if it covered Trulicity?
Different molecule means different formulary placement. Run a fresh prior authorization for Mounjaro — coverage of Trulicity doesn't transfer automatically.
How long does Trulicity stay in my system after the last dose?
Liraglutide has a 13-hour half-life — effects clear in 2-3 days. Daily dosing means transitions are quicker.
Cost comparison
Cash-pay pricing differs significantly between Trulicity and Mounjaro. Run the true-cost calculator with your insurance details for an apples-to-apples comparison including coupons and patient assistance programs. Open true cost calculator →
Provider match
Find a provider that offers Mounjaro
Continuity of care matters during a switch. We compared 12+ telehealth providers ranked by Mounjaro availability, price, and prescriber accessibility.
See top Mounjaro providers →Affiliate disclosure: we earn commission on provider sign-ups. Learn more
Next steps
Before switching, read our full Trulicity review and Mounjaro review. For provider options that carry both medications, see our Trulicity vs Mounjaro comparison and Trulicity alternatives hub.
Sources
- FDA Trulicity prescribing information
- FDA Mounjaro prescribing information
- SURPASS-2 trial (NEJM 2021)
Not medical advice. Switching GLP-1 medications must be done with prescriber supervision. This guide is editorial summary based on published prescribing information and clinical guidance. Full medical disclaimer.